PRAD and BPH samples were analyzed by nucleic acid extraction and PCR, and the expression levels of key molecules in PANoptosis, including ZBP1, RIPK1, CASP6, CASP1, CASP8, and FADD, were identified. The gene discussed is RIPK1; the disease is prostate adenocarcinoma.